EVGN Evogene Ltd Ord

NASDAQ
$0.44

Evogene Ltd Ord (EVGN) SEC Filings

Everything EVGN has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

16 filings
Date Form Filing
4
4
4
4
6-K Delisting
6-K Acquisition Disposition · Capital Raise · Delisting · Earnings Release · Executive Change · Material Agreement · Other
6-K Executive Change · Other
SCHEDULE 13D/A
SCHEDULE 13D/A
6-K
SCHEDULE 13D/A
6-K Investor Presentation
4
6-K Acquisition Disposition · Earnings Release · Guidance Update · Investor Presentation · Restructuring
4
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.